A Registry of COPD Patients to be Used for Future Studies
Launched by PHILIP DIAZ · Dec 23, 2008
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
To develop a cohort of COPD participants for study staff to determine the most likely candidates for future studies and to develop a repository of blood from subjects with COPD for future studies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients who are 18 years of age and older who have been diagnosed with COPD by at least one of the following:
- • clinical history-a documented history of COPD, emphysema, or chronic bronchitis;
- • pulmonary function results (defined as an FEV1/FVC less than 0.7;
- • radiographic results (high-resolution CT findings of emphysema
- Exclusion Criteria:
- • in ability to give informed consent
- • prisoners
- • pregnancy
About Philip Diaz
Philip Diaz is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study design and robust trial management. With a focus on therapeutic areas that address unmet medical needs, Diaz leverages a collaborative approach, engaging with healthcare professionals, regulatory bodies, and patient communities to ensure the highest standards of ethical practice and scientific integrity. By prioritizing patient safety and the generation of meaningful data, Philip Diaz aims to contribute to the development of groundbreaking therapies that enhance quality of life and drive progress in the field of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Philip Diaz, MD
Principal Investigator
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials